Baird analyst Michael Ha lowered the firm's price target on Centene ( CNC ) to $69 from $71 and keeps a Neutral rating on the shares. The firm sees minimal incremental buyers of stocks in the managed care and healthcare facilities group until the policy overhang clears. Baird does not not expect guidance raises as it believes companies will maintain 2025 "conservatism and cushion" given potential Part D and macro headwinds that may evolve later this year. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published first on TheFly - the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Centene is a Missouri-based multi-line managed care enterprise that provides healthcare programs and services for under-insured and uninsured individuals and families.